Global fight against TB misses 2020 WHO milestones, despite progress in certain age groups

FHS
March 26, 2024
11:11 am

The global, national, and regional burden and trends in tuberculosis.

FDA approves Humacyte’s lab-grown blood vessels in milestone for regenerative medicine

Twenty years ago, Laura Niklason founded a company that sounded like something out of science fiction. The Duke University bioengineer and anesthesiologist was working in

December 21, 2024

Anavex, maker of rare disease drug, keeps shifting the goalposts in its clinical trials

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it

August 10, 2023

Study suggests treating anxiety and depression significantly reduces ER visits and rehospitalizations among heart disease patients

A new study looks at this area in order to provide evidence for key recommendations in the treatment of such patients.

March 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.